Asthma-Associated COPD Etiotype: Clinical Features and Inflammatory Patterns in Biological Samples

Area of Science:

• Pulmonology
• Respiratory Medicine
• Immunology

Background:

• Asthma is recognized as a potential cause of chronic obstructive pulmonary disease (COPD), termed the COPD-A etiotype.
• The clinical and inflammatory features of the COPD-A phenotype are not well understood.
• This study investigates COPD-A in non-smoking asthmatics.

Purpose of the Study:

• To characterize the clinical traits of stable asthmatics with persistent airflow limitation indicative of COPD-A.
• To analyze cytokine profiles in asthmatic patients with and without COPD-A.
• To identify potential biomarkers for the COPD-A phenotype.

Main Methods:

• A cross-sectional study of 94 stable asthmatics without significant smoking or environmental exposures.
• COPD-A was defined by post-bronchodilator FEV1/FVC ratio < 0.70.
• Assessed asthma control, quality of life, lung function, and quantified cytokines (IL-5, IL-8, IL-13, IL-17A, IL-17F, IL-25, IL-33, TNF) in nasal lavage, sputum, and blood.

Main Results:

• 44.7% of participants met COPD-A criteria.
• COPD-A patients were older, had longer disease duration, lower FEV1, and poorer asthma control compared to non-COPD-A.
• Elevated IL-8 levels in induced sputum were significantly higher in the COPD-A group and independently predicted COPD-A.

Conclusions:

• Persistent airflow limitation consistent with COPD-A is prevalent in over 40% of non-smoking asthmatics.
• Elevated sputum IL-8 concentrations may serve as a potential biomarker for identifying the COPD-A etiotype.
• Further research is warranted to elucidate the mechanisms and clinical implications of COPD-A.